Embracing Uncertainties Over the Evidence of New Oral Antivirals for COVID‐19: Challenges in Pharmacoepidemiologic Research

Detalles Bibliográficos
Autores principales: Ferreira da Silva, Renato, Silva, Ana Marta, Morato, Manuela, Ribeiro‐Vaz, Inês, Polónia, Jorge Junqueira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878095/
https://www.ncbi.nlm.nih.gov/pubmed/36519976
http://dx.doi.org/10.1002/jcph.2195
_version_ 1784878435413262336
author Ferreira da Silva, Renato
Silva, Ana Marta
Morato, Manuela
Ribeiro‐Vaz, Inês
Polónia, Jorge Junqueira
author_facet Ferreira da Silva, Renato
Silva, Ana Marta
Morato, Manuela
Ribeiro‐Vaz, Inês
Polónia, Jorge Junqueira
author_sort Ferreira da Silva, Renato
collection PubMed
description
format Online
Article
Text
id pubmed-9878095
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-98780952023-01-26 Embracing Uncertainties Over the Evidence of New Oral Antivirals for COVID‐19: Challenges in Pharmacoepidemiologic Research Ferreira da Silva, Renato Silva, Ana Marta Morato, Manuela Ribeiro‐Vaz, Inês Polónia, Jorge Junqueira J Clin Pharmacol Commentary John Wiley and Sons Inc. 2023-01-09 /pmc/articles/PMC9878095/ /pubmed/36519976 http://dx.doi.org/10.1002/jcph.2195 Text en © 2022 The Authors. The Journal of Clinical Pharmacology published by Wiley Periodicals LLC on behalf of American College of Clinical Pharmacology. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Commentary
Ferreira da Silva, Renato
Silva, Ana Marta
Morato, Manuela
Ribeiro‐Vaz, Inês
Polónia, Jorge Junqueira
Embracing Uncertainties Over the Evidence of New Oral Antivirals for COVID‐19: Challenges in Pharmacoepidemiologic Research
title Embracing Uncertainties Over the Evidence of New Oral Antivirals for COVID‐19: Challenges in Pharmacoepidemiologic Research
title_full Embracing Uncertainties Over the Evidence of New Oral Antivirals for COVID‐19: Challenges in Pharmacoepidemiologic Research
title_fullStr Embracing Uncertainties Over the Evidence of New Oral Antivirals for COVID‐19: Challenges in Pharmacoepidemiologic Research
title_full_unstemmed Embracing Uncertainties Over the Evidence of New Oral Antivirals for COVID‐19: Challenges in Pharmacoepidemiologic Research
title_short Embracing Uncertainties Over the Evidence of New Oral Antivirals for COVID‐19: Challenges in Pharmacoepidemiologic Research
title_sort embracing uncertainties over the evidence of new oral antivirals for covid‐19: challenges in pharmacoepidemiologic research
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878095/
https://www.ncbi.nlm.nih.gov/pubmed/36519976
http://dx.doi.org/10.1002/jcph.2195
work_keys_str_mv AT ferreiradasilvarenato embracinguncertaintiesovertheevidenceofneworalantiviralsforcovid19challengesinpharmacoepidemiologicresearch
AT silvaanamarta embracinguncertaintiesovertheevidenceofneworalantiviralsforcovid19challengesinpharmacoepidemiologicresearch
AT moratomanuela embracinguncertaintiesovertheevidenceofneworalantiviralsforcovid19challengesinpharmacoepidemiologicresearch
AT ribeirovazines embracinguncertaintiesovertheevidenceofneworalantiviralsforcovid19challengesinpharmacoepidemiologicresearch
AT poloniajorgejunqueira embracinguncertaintiesovertheevidenceofneworalantiviralsforcovid19challengesinpharmacoepidemiologicresearch

Ejemplares similares